219 related articles for article (PubMed ID: 23918976)
1. Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus.
Bossaller L; Rathinam VA; Bonegio R; Chiang PI; Busto P; Wespiser AR; Caffrey DR; Li QZ; Mohan C; Fitzgerald KA; Latz E; Marshak-Rothstein A
J Immunol; 2013 Sep; 191(5):2104-14. PubMed ID: 23918976
[TBL] [Abstract][Full Text] [Related]
2. TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus.
Bossaller L; Christ A; Pelka K; Nündel K; Chiang PI; Pang C; Mishra N; Busto P; Bonegio RG; Schmidt RE; Latz E; Marshak-Rothstein A
J Immunol; 2016 Aug; 197(4):1044-53. PubMed ID: 27354219
[TBL] [Abstract][Full Text] [Related]
3. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
O' Reilly LA; Tai L; Lee L; Kruse EA; Grabow S; Fairlie WD; Haynes NM; Tarlinton DM; Zhang JG; Belz GT; Smyth MJ; Bouillet P; Robb L; Strasser A
Nature; 2009 Oct; 461(7264):659-63. PubMed ID: 19794494
[TBL] [Abstract][Full Text] [Related]
4. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
6. Membrane-bound and soluble Fas ligands have opposite functions in photoreceptor cell death following separation from the retinal pigment epithelium.
Matsumoto H; Murakami Y; Kataoka K; Notomi S; Mantopoulos D; Trichonas G; Miller JW; Gregory MS; Ksander BR; Marshak-Rothstein A; Vavvas DG
Cell Death Dis; 2015 Nov; 6(11):e1986. PubMed ID: 26583327
[TBL] [Abstract][Full Text] [Related]
7. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.
Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Harris J; Hoi AY; Mackay F; Morand EF
Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32546562
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of the type I interferon receptor protects mice from experimental lupus.
Nacionales DC; Kelly-Scumpia KM; Lee PY; Weinstein JS; Lyons R; Sobel E; Satoh M; Reeves WH
Arthritis Rheum; 2007 Nov; 56(11):3770-83. PubMed ID: 17968932
[TBL] [Abstract][Full Text] [Related]
9. Fas Ligand enhances vessel maturation and inhibits vascular leakage associated with age-related macular degeneration.
Koirala A; Marshak-Rothstein A; Ksander BR; Gregory-Ksander M
Res Sq; 2024 May; ():. PubMed ID: 38766158
[TBL] [Abstract][Full Text] [Related]
10. The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice.
Singh AK; Yang JQ; Parekh VV; Wei J; Wang CR; Joyce S; Singh RR; Van Kaer L
Eur J Immunol; 2005 Apr; 35(4):1143-54. PubMed ID: 15761849
[TBL] [Abstract][Full Text] [Related]
11. Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.
Fingleton B; Carter KJ; Matrisian LM
Cancer Res; 2007 May; 67(10):4800-6. PubMed ID: 17510409
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors.
Hohlbaum AM; Gregory MS; Ju ST; Marshak-Rothstein A
J Immunol; 2001 Dec; 167(11):6217-24. PubMed ID: 11714783
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.
Park H; Jung YK; Park OJ; Lee YJ; Choi JY; Choi Y
J Immunol; 2005 Dec; 175(11):7193-201. PubMed ID: 16301623
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degeneration.
Zhao H; Roychoudhury J; Doggett TA; Apte RS; Ferguson TA
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5321-31. PubMed ID: 23821188
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
[TBL] [Abstract][Full Text] [Related]
16. The membrane-bound but not the soluble form of human Fas ligand is responsible for its inflammatory activity.
Shudo K; Kinoshita K; Imamura R; Fan H; Hasumoto K; Tanaka M; Nagata S; Suda T
Eur J Immunol; 2001 Aug; 31(8):2504-11. PubMed ID: 11500835
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus: "immune privilege"-like state of the autoreactive B cells.
Nagafuchi H; Wakisaka S; Takeba Y; Takeno M; Sakane T; Suzuki N
Clin Exp Rheumatol; 2002; 20(5):625-31. PubMed ID: 12412192
[TBL] [Abstract][Full Text] [Related]
18. The FasLane to ocular pathology-metalloproteinase cleavage of membrane-bound FasL determines FasL function.
Gregory-Ksander M; Marshak-Rothstein A
J Leukoc Biol; 2021 Nov; 110(5):965-977. PubMed ID: 33565149
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory Effect of Agave tequilana Evaluated on an Autoimmunity Like-SLE Model Induced in Balb/c Mice with Pristane.
Gutiérrez Nava ZJ; Jiménez-Aparicio AR; Herrera-Ruiz ML; Jiménez-Ferrer E
Molecules; 2017 May; 22(6):. PubMed ID: 28587079
[TBL] [Abstract][Full Text] [Related]
20. Effect of oestrogen on T cell apoptosis in patients with systemic lupus erythematosus.
Kim WU; Min SY; Hwang SH; Yoo SA; Kim KJ; Cho CS
Clin Exp Immunol; 2010 Sep; 161(3):453-8. PubMed ID: 20529085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
